Literature DB >> 9247584

Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.

S R Burrows1, S L Silins, R Khanna, J M Burrows, M Rischmueller, J McCluskey, D J Moss.   

Abstract

In the present report, cytotoxic T lymphocyte (CTL) clones are described that display dual specificity for one of two common human leukocyte antigens (HLA B14 or B35) as alloantigens, and an immunodominant epitope (FLRGRAYGL) from Epstein-Barr virus (EBV) that binds to HLA B8. These T cell clonotypes were isolated from several unrelated HLA B8+, EBV-exposed individuals, and each distinct cross-reactivity pattern was associated with a common, public T cell receptor (TCR). In some individuals, CTL cross-reactive with these alloantigens completely dominated the memory response to this EBV epitope. Moreover, these memory T cells to EBV could be reactivated as a significant component of the repertoire of CTL responding to allogeneic stimulator cells expressing either HLA B14 or B35. These data illustrate how a history of infection with an immunogenic virus such as EBV can augment responsiveness to particular alloantigens; such influences may underlie the observed clinical association between herpesvirus infection and both allograft rejection and graft-versus-host disease. We have also explored the molecular basis for T cell cross-reactivity with alloantigens using the HLA B35 allo-reactive CTL clonotype. To elucidate the structural features of peptides that may be cross-recognized by these T cells, mono-substituted analogs of the viral epitope were screened for recognition, revealing broad specificity for major histocompatibility complex (MHC)-bound peptide. Based on the particular amino acid changes tolerated by the CTL at each peptide position, the human protein sequence database was searched for possible sequences that were recognized in association with HLA B35. Four peptides were identified (MPEATVYGL, IPIAPVYGM, KPSPPYFGL, and KPIVVLHGY) that were powerful activating ligands for the CTL when presented on HLA B35 but not B8. Thus, equivalent epitopes, capable of fully activating a single TCR, were formed by peptides with minimal obvious sequence homology bound to either HLA B8 or B35. These data indicate that degenerate peptide recognition by TCR may play an important role in the vigorous response of self-MHC-restricted T cells to alloantigens.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9247584     DOI: 10.1002/eji.1830270720

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  49 in total

Review 1.  The immunology of Epstein-Barr virus infection.

Authors:  D J Moss; S R Burrows; S L Silins; I Misko; R Khanna
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

Review 2.  Heterologous immunity between viruses.

Authors:  Raymond M Welsh; Jenny W Che; Michael A Brehm; Liisa K Selin
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

Review 3.  T-cell activation and transplantation tolerance.

Authors:  Bhavana Priyadharshini; Dale L Greiner; Michael A Brehm
Journal:  Transplant Rev (Orlando)       Date:  2011-11-08       Impact factor: 3.943

4.  Crystal structure of the human T cell receptor CD3 epsilon gamma heterodimer complexed to the therapeutic mAb OKT3.

Authors:  Lars Kjer-Nielsen; Michelle A Dunstone; Lyudmila Kostenko; Lauren K Ely; Travis Beddoe; Nicole A Mifsud; Anthony W Purcell; Andrew G Brooks; James McCluskey; Jamie Rossjohn
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-10       Impact factor: 11.205

5.  Evolving concepts of specificity in immune reactions.

Authors:  Herman N Eisen; Arup K Chakraborty
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

6.  Contributions of direct and indirect alloresponses to chronic rejection of kidney allografts in nonhuman primates.

Authors:  Ognjenka Nadazdin; Svjetlan Boskovic; Siew-Lin Wee; Hiroshi Sogawa; Ichiro Koyama; Robert B Colvin; R Neal Smith; Georges Tocco; David H O'Connor; Julie A Karl; Joren C Madsen; David H Sachs; Tatsuo Kawai; A Benedict Cosimi; Gilles Benichou
Journal:  J Immunol       Date:  2011-09-28       Impact factor: 5.422

7.  Simultaneous Recognition of Allogeneic MHC and Cognate Autoantigen by Autoreactive T Cells in Transplant Rejection.

Authors:  Adam L Burrack; Laurie G Landry; Janet Siebert; Marilyne Coulombe; Ronald G Gill; Maki Nakayama
Journal:  J Immunol       Date:  2018-01-08       Impact factor: 5.422

8.  Cytotoxic herpes simplex type 2-specific, DQ0602-restricted CD4 T+-cell clones show alloreactivity to DQ0601.

Authors:  Sandra Reichstetter; Nathan E Standifer; Kelly A Geubtner; Andrew W Liu; Stacy L Agar; William W Kwok
Journal:  Immunology       Date:  2006-03       Impact factor: 7.397

Review 9.  Fixed drug eruption: a prototypic disorder mediated by effector memory T cells.

Authors:  Yoshiko Mizukawa; Tetsuo Shiohara
Journal:  Curr Allergy Asthma Rep       Date:  2009-01       Impact factor: 4.806

Review 10.  Evolution and function of the TCR Vgamma9 chain repertoire: It's good to be public.

Authors:  C David Pauza; Cristiana Cairo
Journal:  Cell Immunol       Date:  2015-03-04       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.